Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
Daniel Keane

Hope for bladder cancer patients as new drug combination doubles survival

A new drug combination can double the overall survival for patients with bladder cancer that has spread, a study has found.

Researchers at Barts Health NHS Trust and Queen Mary University found that giving patients enfortumab vedotin and pembrolizum can stop their disease from getting worse and help them live twice as long as those given chemotherapy.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.